Wells Fargo & Company Lowers Molina Healthcare (NYSE:MOH) Price Target to $410.00

Molina Healthcare (NYSE:MOH - Free Report) had its price target cut by Wells Fargo & Company from $440.00 to $410.00 in a research note issued to investors on Monday, Benzinga reports. They currently have an equal weight rating on the stock.

Other equities analysts have also issued reports about the company. Cantor Fitzgerald reaffirmed an overweight rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. Bank of America lowered Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 target price for the company. in a research report on Thursday, March 28th. StockNews.com downgraded Molina Healthcare from a strong-buy rating to a buy rating in a research note on Thursday, February 8th. Truist Financial increased their price target on Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a research note on Tuesday, February 20th. Finally, Barclays began coverage on Molina Healthcare in a research note on Wednesday, March 6th. They issued an equal weight rating and a $437.00 target price for the company. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Molina Healthcare has an average rating of Hold and an average target price of $393.09.

Molina Healthcare Price Performance

MOH stock traded down $15.73 during midday trading on Monday, reaching $360.84. The company had a trading volume of 839,496 shares, compared to its average volume of 389,040. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.54 and a quick ratio of 1.54. The company has a market capitalization of $21.14 billion, a price-to-earnings ratio of 19.21, a price-to-earnings-growth ratio of 1.06 and a beta of 0.47. Molina Healthcare has a 1-year low of $266.35 and a 1-year high of $423.92. The stock has a 50 day moving average price of $395.20 and a 200-day moving average price of $370.65.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, February 7th. The company reported $4.38 earnings per share for the quarter, topping the consensus estimate of $4.31 by $0.07. The company had revenue of $9.05 billion for the quarter, compared to analysts' expectations of $8.35 billion. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The business's quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the business posted $4.10 earnings per share. Equities research analysts expect that Molina Healthcare will post 23.62 earnings per share for the current year.

Insider Buying and Selling at Molina Healthcare

In other news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Molina Healthcare news, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the sale, the director now owns 11,207 shares of the company's stock, valued at approximately $4,494,567.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard M. Schapiro sold 711 shares of the firm's stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares of the company's stock, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock worth $6,472,517 over the last ninety days. Company insiders own 1.11% of the company's stock.

Hedge Funds Weigh In On Molina Healthcare

Several institutional investors and hedge funds have recently modified their holdings of MOH. Annis Gardner Whiting Capital Advisors LLC purchased a new position in Molina Healthcare in the third quarter worth approximately $30,000. ST Germain D J Co. Inc. acquired a new stake in shares of Molina Healthcare in the second quarter valued at $33,000. McIlrath & Eck LLC acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at $34,000. Coppell Advisory Solutions Corp. acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at $34,000. Finally, VisionPoint Advisory Group LLC raised its stake in shares of Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company's stock valued at $36,000 after acquiring an additional 57 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.